NCM · —
Barinthus Biotherapeutics plc (BRNS) Stock
$0.67
+4.69%
NCM: BRNS
—
—
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About Barinthus Biotherapeutics plc
—
the stock is valued at a price-to-earnings (P/E) ratio of -0.41. Over the past 52 weeks the stock has ranged between $0.51 and $2.91, and currently trades 77.0% below its 52-week high.
On profitability, Barinthus Biotherapeutics plc generates a return on equity (ROE) of -89.19%, return on capital employed of -80.68%.